The uptake of recombinant Factor VIII in the Netherlands
Open Access
- 30 October 2002
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 119 (2), 332-341
- https://doi.org/10.1046/j.1365-2141.2002.03903.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Hemophilias — From Royal Genes to Gene TherapyNew England Journal of Medicine, 2001
- Product choice and haemophilia treatment in the NetherlandsHaemophilia, 2001
- Assessment of biotechnology drugs: what are the issues?Health Policy, 1999
- Hepatitis C infection and viremia in Dutch Hemophilia patientsJournal of Medical Virology, 1995
- Hemophilia ANew England Journal of Medicine, 1994
- Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIThe Lancet, 1993
- Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of InhibitorsNew England Journal of Medicine, 1993
- Trying times for human insulinNature, 1992
- Hemophilia treatment in historical perspective: a review of medical and social developmentsAnnals of Hematology, 1991
- HYPOGLYCAEMIA AND HUMAN INSULINThe Lancet, 1989